Turenne Andre 4
4 · Voyager Therapeutics, Inc. · Filed Jul 18, 2018
Insider Transaction Report
Form 4
Turenne Andre
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2018-07-16+650,000→ 650,000 totalExercise: $18.03Exp: 2028-07-16→ Common Stock (650,000 underlying)
Footnotes (1)
- [F1]This stock option was not granted pursuant to any pre-existing equity incentive plan of Voyager Therapeutics, Inc. (the "Company"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4). The vesting commencement date (the "Vesting Commencement Date") of the option is July 16, 2018. The option vests over four years, with 25% of the shares of common stock underlying the option vesting upon the one-year anniversary of the Vesting Commencement Date and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued employment.